Schonfeld Strategic Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,800
Closed -$160K 2451
2024
Q1
$160K Buy
+10,800
New +$160K ﹤0.01% 1616